Home › Cardiovascular Disease › Kansas › Overland Park
Cardiovascular Disease clinical trials in Overland Park, KS
3 studies for Cardiovascular Disease are looking for participants at sites in and around Overland Park (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- Midwest Heart and Vascular Specialists, Overland Park
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecruitingPhase 3
- Midwest Heart and Vascular Specialists, Overland Park
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
RecruitingPhase 3
- Midwest Heart and Vascular Specialists, Overland Park
Cardiovascular Disease trials in other cities
- Boston, MA37 studies
- New York City, NY33 studies
- Washington, DC28 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Cleveland, OH22 studies
- Atlanta, GA22 studies
- Chicago, IL21 studies
- Philadelphia, PA21 studies
- Pittsburgh, PA20 studies
- St. Louis, MO20 studies
- Nashville, TN18 studies
Other studies in Overland Park
- Non-Small Cell Lung Cancer16 studies
- Acute Myeloid Leukemia11 studies
- Lung Cancer11 studies
- Breast Cancer10 studies
- Atrial Fibrillation8 studies
- Colorectal Cancer8 studies
- Obesity7 studies
- Pancreatic Cancer7 studies
- Prostate Cancer7 studies
- Melanoma6 studies
- Overweight6 studies
- Ovarian Cancer6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.